Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Opioid Bills Could Enhance US FDA Approval, Withdrawal Authority

Opioid Law Concept 3D Illustration

Related Content

Charleston's Anti-Emetic/Opioid Combo Flops At US FDA Panel Over Postmarketing, Dosage Concerns

Feb 14 2018

Temple: FDASIA Directs FDA To Learn To Use Existing Authority

Dec 24 2012

Opioid Packaging: Is Non-Inferiority Enough For A New Claim?

Dec 12 2017

Curtain Falls On Opana ER As Endo Agrees To US FDA Withdrawal Request

Jul 06 2017

US FDA To Withdraw Pain Drug Guidance As Part Of Response To Opioid Epidemic

Aug 30 2018

Over-Legislating On Opioids? US FDA May Get New Authorities And Unwanted Tasks

Jun 06 2018

Related Companies

Endo, Inc.

Additional Topics

United States Review Pathway Regulation FDA Neurology BioPharmaceutical

More from Review Pathways

More from Pathways & Standards

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window